PT-141 - Hormone Harmony Clinic

What is PT-141?

PT-141 is a peptide hormone used to treat sexual dysfunction and boost libido. It works by activating the brain's melanocortin receptors which regulate sexual arousal and appetite.

Some key things to know about PT-141:

• Originally developed by Palatin Technologies, PT-141 is also known as Bremelanotide. It's marketed under the brand name Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women.
• PT-141 is administered as a subcutaneous injection (shot under the skin), typically in the abdomen or thigh. Effects can last between 6-72 hours depending on the dosage.
• By targeting the central nervous system, PT-141 can increase sexual desire and arousal. In studies, over 60% of women reported improvement in satisfying sexual events with PT-141.
• Side effects can include nausea, flushing, headache and vomiting. PT-141 may not be safe for those with cardiovascular risk factors.

So in summary, PT-141 is a melanocortin-based peptide hormone injection that can effectively improve female sexual arousal and desire in the short-term. But side effects are common.

If you're struggling with low libido or sexual dysfunction, consider contacting my clinic Hormone Harmony Clinic to explore potential treatment options like PT-141. Our caring medical team can evaluate your symptoms, health history and develop an integrated plan to help you reclaim a satisfying sex life. We accept most major insurance plans and can even schedule Skype consultations for your convenience. Renewed passion is just a call away!

Now to dive deeper into some common questions about this unique peptide hormone:

How does PT-141 work to boost female arousal?

PT-141 activates melanocortin receptors MC3-R and MC4-R in the hypothalamus, limbic system and other areas of the brain critical for sexual response. This increases dopamine and norepinephrine activity and incites a signaling cascade that boosts arousal.

What results did clinical trials show for PT-141 in treating HSDD?

In phase 3 trials, 60-72% of premenopausal women with HSDD reported increases in sexual desire and satisfying sexual events when taking PT-141. Effects occurred rapidly and lasted 6-72 hours depending on dosage.

What factors can impact results with PT-141 treatment?

PT-141 response varies based on individual factors like age, hormonal status, dose/frequency and source of sexual dysfunction. Combining PT-141 with counseling or other modalities may improve outcomes. Ongoing assessment is key.

I hope this overview on the peptide hormone PT-141 has been helpful! Our experienced staff at Hormone Harmony Clinic provides compassionate care and expert solutions for low libido, menopause, ED and other intimate health conditions. Contact us today to transform your sexual vitality!